Skip to main content
Premium Trial:

Request an Annual Quote

Farewell, Compaq, Hello IBM: Celera and ABI Overhaul Computer Infrastructure

NEW YORK, Sept. 26-Celera Genomics and Applied Biosystems are overhauling their joint computer infrastructure with hardware and operating systems from IBM and storage systems from EMC Corporation, the companies said today.


With this deal, the two Applera companies bid goodbye to Compaq, their  longtime computing partner.


Beginning this month, IBM will install a supercomputer structure in the companies' Rockville headquarters that includes 12 p690 systems running AIX, IBM's UNIX system. With a projected peak speed of two teraflops, the fully installed system is expected to be one of the fastest in the world.


The Applera businesses have also purchased 150 terabytes of networked storage from EMC, and will use EMC open software for data management, creating a global storage area network that will consolidate its massive biological databases.


Financial specifics of the two deals were not revealed.


Celera will use the new IBM system to identify and validate drug targets and potential diagnostic markers. ABI will rely on the infrastructure to support its database and information products, including the Celera DiscoverySystem mammalian genome platform.


The two Applera businesses also plan to work collaboratively with the computer giant to improve drug target discovery and develop and co-market new life sciences applications for IBM products.


The overhaul will better suit Applera's newly reorganized divisions, said a company representative in a statement. Last spring, Celera gave up the gene sequencing business to focus on drug discovery.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.